Inventor · disambiguated record
Matthew G. Fury
Also filed as: FURY MATTHEW G
3 granted patents·6 pending applications·3 citations·filing 2017–2023
57Inventor score
Files withREGENERON PHARMA9
Top patents by PatentIndex Score
9 records- 0178US11505600B2Methods of treating skin cancer by administering a PD-1 inhibitorREGENERON PHARMA·Filed 2019·Granted Nov 22, 2022·1 cites·20 claims
- 0272US10457725B2Methods of treating skin cancer by administering a PD-1 inhibitorREGENERON PHARMA·Filed 2017·Granted Oct 29, 2019·2 cites·18 claims
- 0372US2023227542A1Methods of treating skin cancer by administering a pd-1 inhibitorREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0463US12473364B2Intralesional administration of PD-1 inhibitors for treating skin cancerREGENERON PHARMA·Filed 2019·Granted Nov 18, 2025·0 cites·31 claims
- 0563US2024270849A1Methods of treating cancer with bispecific egfr xcd28 antibodies alone or in combination with anti-pd-1 antibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0656US2023323470A1Methods of treating cancer by administering a pd-1 inhibitorREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0752US2021403567A1Methods of treating cervical cancer by administering a pd-1 inhibitorREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 0848US2022259313A1Administration of a pd-1 inhibitor for for treating skin cancerREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 0948US2025326846A1Methods of treating cancer in immunosuppressed or immunocompromised patients by administering a pd-1 inhibitorREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew G. Fury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →